 
| Course: |
Adult Sickle Cell Disease
|
| Target Audience: |
| This CME activity is intended for emergency physicians and family physicians. |
| Sponsor: |
| This activity is sponsored by AHC Media. |
| Accreditation: |
| AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| Credit Designation: |
AHC Media designates this enduring material for a maximum of 2.3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is approved by the American College of Emergency Physicians for 2.25 hours of ACEP Category 1 credits.
Emergency Medicine Reports has been reviewed and is acceptable for up to 1.5 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 01/01/12. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue. |
| Faculty |
Editors
Gregory R. Wise, MD, FACP
Associate Professor of Medicine
Wright State University
Dayton, OH;
Vice President, Medical Affairs
Kettering Medical Center
Kettering, OH
J. Stephan Stapczynski, MD
Chair
Emergency Medicine Department
Maricopa Medical Center
Phoenix, Arizona
CME Question Reviewer
Roger Farel, MD
Retired
Newport Beach, CA
Executive Editor
Shelley Mark
Managing Editor
Leslie
Hamlin
Neill Kimball
Author
Karen Kirkham, MD, FACP
Associate Professor and Vice-Chair for Undergraduate Medical Education
Department of Internal Medicine
Boonshoft Wright State School of Medicine
Dayton, OH.
Peer Reviewer
Alecia C. Nero, MD
Assistant Professor of Internal Medicine
Hematology/Oncology Division
University of Texas Southwestern Medical Center
Dallas, TX.
|
| Subjects: |
- Adult Sickle Cell Disease
|
| Objectives: |
- Recognize or increase index of suspicion for specific conditions
- State the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
- Apply state-of-the-art diagnostic and therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed.
- Discuss the differential diagnosis of the entity discussed.
- Explain both likely and rare complications that may occur.
|
| Financial Disclosure: |
To reveal any potential bias in this publication, and in
accordance with Accreditation Council for Continuing
Medical Education guidelines, we disclose that Roger Farel, MD (CME question reviewer) owns stock in Johnson& Johnson. J. Stephan Stapczynski, MD (editor) owns stock in Bristol
Myers Squibb. Karen Kirkham, MD, FACP (author), Alecia C. Nero, MD (peer
reviewer), Gregory R. Wise, MD, FACP (editor), Ms. Coplin (executive editor), Neill Kimball (managing editor), Shelley Mark (executive editor), and Leslie Hamlin (managing editor) report no
financial relationships with companies related to the field
of study covered by this CME activity.
Copyright 2012 AHC Media LLC. All rights reserved.
|
- You are not currently logged in.
- To view content articles and complete the post-test for this course, please login or register now
|
|
